Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1800 of 3173 entries
View as:

PF-04191834 Single Dose Bronchodilatory Study In Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT00723021 Org: User:
Start: 07/31/08 End: 07/31/09 Due: 07/31/10

Study of Different Doses of a Novel Treatment for Onychomycosis

Phase: N/A Priority: Normal
NCT ID: NCT00679965 Org: User:
Start: 02/28/06 End: 07/31/07 Due: 07/31/08

Safety And Efficacy Study Of Palbociclib Plus Cetuximab Versus Cetuximab To Treat Head And Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02499120 Org: User:
Start: 09/10/15 End: 09/07/22 Due: 09/07/23

A Study To Evaluate The Safety And Pharmacokinetic Profile Of A P38 Inhibitor (PH-797804) In Subjects With Rheumatoid Arthritis Who Are Also Taking Methotrexate

Phase: N/A Priority: Normal
NCT ID: NCT00620685 Org: User:
Start: 03/31/08 End: 10/31/08 Due: 10/31/09

Study to Estimate the Effects of Hepatic Impairment on the Pharmacokinetics (PK) of PF-07321332

Phase: N/A Priority: Normal
NCT ID: NCT05005312 Org: User:
Start: 08/31/21 End: 12/07/21 Due: 12/07/22

Long-Term Safety Study of Inhaled Insulin: An Up to Four-Year Extension of Therapy in Subjects With Type 1 or Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00143247 Org: User:
Start: 03/31/03 End: 01/31/08 Due: 01/31/09

Study of CP-751,871 in Combination With Carboplatin and Paclitaxel in Advanced Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00603538 Org: User:
Start: 01/31/08 End: 05/31/09 Due: 05/31/10

Single Dose, Repeated Dose, and Conditional Food Effect Study of PF-05221304 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02871037 Org: User:
Start: 08/31/16 End: 03/31/17 Due: 03/31/18

A Comparison Of A Single PF-04634817 Tablet Dose Compared With A Solution In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01247883 Org: User:
Start: 10/31/10 End: 12/31/10 Due: 12/31/11

Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)

Phase: N/A Priority: Normal
NCT ID: NCT00998309 Org: User:
Start: 10/31/09 End: 01/31/11 Due: 01/31/12

Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01338870 Org: User:
Start: 06/30/11 End: 03/31/12 Due: 03/31/13

A Study to Learn How Different Forms of the Study Medicine Called PF-06954522 Are Taken up Into the Blood in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06393517 Org: User:
Start: 04/30/24 End: 09/01/24 Due: 09/01/25

A Comparison Of Valdecoxib 20 Mg Twice Daily and 40 Mg Daily and Placebo In The Treatment Of Sore Throat

Phase: N/A Priority: Normal
NCT ID: NCT00647829 Org: User:
Start: 02/28/03 End: 12/31/03 Due: 12/31/04

A Phase 2 Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of PF-06252616 in Duchenne Muscular Dystrophy

Phase: N/A Priority: Normal
NCT ID: NCT02310763 Org: User:
Start: 11/24/14 End: 11/23/18 Due: 11/23/19

A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Healthy Males

Phase: N/A Priority: Normal
NCT ID: NCT02306876 Org: User:
Start: 01/19/15 End: 06/14/16 Due: 06/14/17

A Study to Learn How the Body Processes the Study Medicine Called Osivelotor (PF-07940367) in People With Loss of Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT06340347 Org: User:
Start: 04/30/24 End: 09/18/24 Due: 09/18/25

A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01028911 Org: User:
Start: 12/31/09 End: 05/31/10 Due: 05/31/11

Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement

Phase: N/A Priority: Normal
NCT ID: NCT02674386 Org: User:
Start: 08/23/16 End: 07/15/19 Due: 07/15/20

Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17

Phase: N/A Priority: Normal
NCT ID: NCT00056381 Org: User:
Start: 07/31/03 End: 06/30/04 Due: 06/30/05

Study To Assess The Reproducibility And Sensitivity Of Quantitative Sensory Testing In Patients With Neuropathic Pain

Phase: N/A Priority: Normal
NCT ID: NCT01117766 Org: User:
Start: 12/31/06 End: 09/30/09 Due: 09/30/10

A Study In Healthy People To Evaluate Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of Multiple Oral Doses Of PF-06743649

Phase: N/A Priority: Normal
NCT ID: NCT02151617 Org: User:
Start: 06/30/14 End: 12/31/14 Due: 12/31/15

A Study to Test a New Decongestant in Patients With Allergic Rhinitis Following a Nasal Allergen Challenge

Phase: N/A Priority: Normal
NCT ID: NCT00562120 Org: User:
Start: 12/31/07 End: 08/31/08 Due: 08/31/09

A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1

Phase: N/A Priority: Normal
NCT ID: NCT00824369 Org: User:
Start: 07/31/09 End: 07/31/13 Due: 07/31/14

Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00678626 Org: User:
Start: 04/30/09 End: 09/30/11 Due: 09/30/12

A 52-Week Placebo-Controlled Study Evaluating the Safety of Varenicline

Phase: N/A Priority: Normal
NCT ID: NCT00143299 Org: User:
Start: 10/31/03 End: 03/31/05 Due: 03/31/06